Answers are grounded in this paper and cite their sources.
3-Aminopyridazines 17 and 3-hydrazinopyridazines 18 were used as building blocks for the preparation of various types of functionalized, pyridazine ring containing compounds. 3-Aminopyridazines were employed in the synthesis of 3-(6-chloroimidazo[1,2-b]pyridazin-2-yl)alanines 26, 27 and for the preparation of 3-amino-4H-pyrimido[1,2-b]pyridazin-4-ones 103, intermediates in the ‘ring switching’ synthesis of alkyl 1-pyridazin-3-yl-1,2,3-triazole-4-carboxylates 106.On the other hand, hydrazinopyridazines 18 were employed in a two-step preparation of 3-functionalized 1,2,4-triazolo[4,3-b]pyridazines via condensation with functionalized aldehydes and their enamino analogs followed by oxidative cyclization of the intermediate hydrazones. In this manner, 1,2,4-triazolo[4,3-b]pyridazin-3-yl substituted alanines 29, 30, polyols 33, 39–48, C-nucleosides 49, 50, and terpenes 58, 62, 64–69 were prepared. In another general approach, 3-hydrazinopyridazines 18 were treated with functionalized enaminones as 1,3-dielectrophiles to give the 1-(substituted pyridazin-3-yl)-1H-pyrazole derivatives containing an ester 72, 73, 75, 76, alanine 79, 84, 85, 87, 2-phenylethylamine 97, 99, and β-amino alcohol functional element 98, 100. In the reaction of 4-oxohomoglutamate 82 with hydrazine hydrate and methyl hydrazine, chiral functionalized tetrahydropyridazinones 88a,b were obtained.
No takes yet. Share an insight, caveat, or question.
Jurij Svete (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: